Legal & General Group Plc Takes $60.52 Million Position in The Cooper Companies, Inc. $COO

Key Points

• Legal & General Group acquired 843,973 shares of Cooper Companies valued at approximately $60.5 million, representing about 0.43% of the company. Institutional investors collectively own 24.39% of COO.
• Cooper Companies reported quarterly EPS of $1.21, beating estimates by $0.11, while revenue rose 7.9% year over year to $1.08 billion. Management issued fiscal 2026 EPS guidance of $4.58–$4.66.
• Analyst sentiment is mixed, with a consensus “Hold” rating and an average price target of $81.64; the stock recently traded at $71.17, up 0.3%.

Legal & General Group Plc purchased a new stake in shares of The Cooper Companies, Inc. (NASDAQ:COO - Free Report) during the 2nd quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor purchased 843,973 shares of the medical device company's stock, valued at approximately $60,521,000. Legal & General Group Plc owned approximately 0.43% of Cooper Companies at the end of the most recent quarter.

Several other large investors have also recently added to or reduced their stakes in the company. BlackRock Inc. bought a new position in shares of Cooper Companies in the 2nd quarter worth about $1,077,762,000. State Street Corp boosted its holdings in shares of Cooper Companies by 2.4% in the 4th quarter. State Street Corp now owns 8,793,747 shares of the medical device company's stock valued at $720,736,000 after buying an additional 207,195 shares during the period. Wellington Management Group LLP boosted its holdings in shares of Cooper Companies by 332.9% in the 3rd quarter. Wellington Management Group LLP now owns 6,184,992 shares of the medical device company's stock valued at $424,043,000 after buying an additional 4,756,178 shares during the period. Price T Rowe Associates Inc. MD grew its position in shares of Cooper Companies by 58.8% during the 4th quarter. Price T Rowe Associates Inc. MD now owns 6,028,821 shares of the medical device company's stock valued at $494,123,000 after buying an additional 2,231,568 shares during the last quarter. Finally, Generation Investment Management LLP bought a new stake in shares of Cooper Companies during the 2nd quarter valued at about $356,304,000. 24.39% of the stock is currently owned by institutional investors.

Cooper Companies Trading Up 0.3%

Cooper Companies stock opened at $71.17 on Friday. The company has a quick ratio of 0.78, a current ratio of 1.27 and a debt-to-equity ratio of 0.23. The firm has a 50-day moving average price of $72.56 and a two-hundred day moving average price of $70.88. The firm has a market capitalization of $13.88 billion, a price-to-earnings ratio of 60.31, a PEG ratio of 1.85 and a beta of 0.83. The Cooper Companies, Inc. has a 52-week low of $58.89 and a 52-week high of $89.83.

Cooper Companies (NASDAQ:COO - Get Free Report) last announced its quarterly earnings results on Thursday, June 4th. The medical device company reported $1.21 EPS for the quarter, beating the consensus estimate of $1.10 by $0.11. The company had revenue of $1.08 billion for the quarter, compared to analyst estimates of $1.05 billion. Cooper Companies had a net margin of 5.57% and a return on equity of 10.88%. Cooper Companies's revenue was up 7.9% compared to the same quarter last year. During the same quarter last year, the business earned $0.96 earnings per share. Cooper Companies has set its FY 2026 guidance at 4.580-4.660 EPS. Sell-side analysts expect that The Cooper Companies, Inc. will post 4.63 earnings per share for the current year.

Analyst Ratings Changes

A number of brokerages have issued reports on COO. UBS Group started coverage on shares of Cooper Companies in a report on Tuesday, July 28th. They issued a "neutral" rating and a $75.00 target price on the stock. Needham & Company LLC dropped their price target on Cooper Companies from $101.00 to $86.00 and set a "buy" rating on the stock in a research report on Friday, June 5th. The Goldman Sachs Group set a $61.00 price target on Cooper Companies in a report on Wednesday, May 27th. Wells Fargo & Company restated a "sell" rating and set a $66.00 price objective (down from $82.00) on shares of Cooper Companies in a research report on Friday, June 5th. Finally, Robert W. Baird lowered their price objective on Cooper Companies from $98.00 to $85.00 and set an "outperform" rating for the company in a research note on Friday, June 5th. One investment analyst has rated the stock with a Strong Buy rating, seven have given a Buy rating, six have assigned a Hold rating and three have issued a Sell rating to the stock. Based on data from MarketBeat, the company presently has a consensus rating of "Hold" and a consensus target price of $81.64.

About Cooper Companies

Cooper Companies, Inc NASDAQ: COO is a global medical device company headquartered in San Ramon, California. Founded in 1958, the company has grown through strategic acquisitions and organic development to become a major provider of vision care and women's health products. Cooper Companies operates through two primary business segments—CooperVision and CooperSurgical—each serving specialized markets within the healthcare industry.

The CooperVision segment develops, manufactures and markets a broad range of soft contact lenses, as well as related accessories.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.

Continue following MarketBeat

Add MarketBeat as your preferred source on Google to see our latest stories in your feed.

Add As Preferred Source